Fibromyalgia
Fibromyalgia is a long-term condition marked by widespread pain throughout the muscles and soft tissues, often accompanied by persistent fatigue, disrupted sleep, and heightened sensitivity to pressure. It does not cause measurable inflammation or joint damage, which is why it often goes undiagnosed for years. The condition affects roughly 2-4% of people globally, with higher rates among women, and diagnosis rates have risen as awareness has grown.
Key points
- Pain spreads across the muscles and soft tissue without any measurable inflammation, which is part of why diagnosis often takes years.
- Ongoing tiredness, poor sleep, and unusually strong sensitivity to touch or pressure typically go alongside the pain.
- Milnacipran and related antidepressants work on the brain and spinal cord’s pain signalling rather than on any physical tissue damage.
Managing the pain
There is no single cure, so treatment focuses on reducing pain intensity and improving daily function. Medicines in the antidepressants class, including milnacipran, are commonly used because they act on pain-processing pathways in the brain and spinal cord rather than targeting tissue damage directly. Low-impact exercise, paced activity, and cognitive behavioural therapy are consistently shown to help alongside any medicine. Poor sleep tends to worsen pain, so addressing sleep quality is a practical early step. If symptoms feel severe or are disrupting work and relationships, a doctor can help confirm the diagnosis and put together a combined plan.